[Skip to Content]
[Skip to Content Landing]
Medical News & Perspectives
May 2, 2007

Scientists Warn NIH Funding Squeeze Hampering Biomedical Research

JAMA. 2007;297(17):1867-1868. doi:10.1001/jama.297.17.1867

The United States' preeminence in health care research and its scientists' ability to conduct the basic and clinical studies necessary to create innovative treatments for a variety of diseases and conditions could be severely damaged if Congress continues to fund the National Institutes of Health (NIH) at recent levels.

So warned members of several major research universities on March 19, during testimony before the Senate Appropriations Subcommittee on Labor, Health and Human Services, and Education. “To be frank, my 3 decades in clinical neurology and basic neuroscience research at Yale, Harvard, and Johns Hopkins have convinced me that the recently flat NIH budget is stifling creative, high-risk research endeavors,” testified Stephen M. Strittmatter, MD, PhD, professor of neurology at Yale University School of Medicine in New Haven, Conn.